Detalles de la búsqueda
1.
Minimal cross-over between mutations associated with Omicron variant of SARS-CoV-2 and CD8+ T cell epitopes identified in COVID-19 convalescent individuals
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-471446
2.
A hemagglutination-based, semi-quantitative test for point-of-care determination of SARS-CoV-2 antibody levels
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21256452
3.
CD8+ T cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21251585
4.
SARS-CoV-2 mRNA vaccination elicits broad and potent Fc effector functions to VOCs in vulnerable populations
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22280000
5.
Kinetics of SARS-CoV-2 antibody responses pre- and post- COVID-19 convalescent plasma transfusion in patients with severe respiratory failure: an observational case-control study
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20247007
6.
Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22270718
7.
Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21265574
8.
Differentiation of SARS-CoV-2 naturally infected and vaccinated individuals in an inner-city emergency department
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21264968
9.
Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21261710
10.
Neutralizing IFNL3 Autoantibodies in Severe COVID-19 Identified Using Molecular Indexing of Proteins by Self-Assembly
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-432977
11.
CD8+ T cell responses in convalescent COVID-19 individuals target epitopes from the entireSARS-CoV-2 proteome and show kinetics of early differentiation
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-330688
12.
Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21250717
13.
SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapy
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20196154
14.
Mitochondrial induced T cell apoptosis and aberrant myeloid metabolic programs define distinct immune cell subsets during acute and recovered SARS-CoV-2 infection
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20186064
15.
Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point of Care Testing
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20166041
16.
Influenza vaccination reveals and partly reverses sex dimorphic immune imprints associated with prior mild COVID-19
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22271138
17.
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20248294
18.
Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20184788
19.
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21267485
20.
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21267611
Resultados
1 -
20
de 20
1
Próxima >
>>